Probiotics for childhood functional gastrointestinal disorders: A systematic review and meta-analysis

Acta Paediatrica, International Journal of Paediatrics

Volumn 103, Issue 4, 2014, Pages 365-372

  Korterink, Judith J ^a   Ockeloen, Lize ^b   Benninga, Marc A ^b   Tabbers, Merit M ^b   Hilbink, Mirrian ^a   Deckers Kocken, Judith M ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Children; Constipation; Functional abdominal pain; Functional gastrointestinal disorders; Probiotic

Indexed keywords

MAGNESIUM OXIDE; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADOLESCENT DISEASE; BLOATING; CHILDHOOD DISEASE; CONSTIPATION; DEFECATION DISORDER; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; FECES INCONTINENCE; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84896134665     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12513     Document Type: Review

References (36)

1. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999; 45 (Suppl 2): II60-8
2. Chitkara DK, Rawat DJ, Talley NJ,. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol 2005; 100: 1868-75.
3. van den Berg MM, Benninga MA, Di Lorenzo C,. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol 2006; 101: 2401-9.
4. Varni JW, Lane MM, Burwinkle TM, Fontaine EN, Youssef NN, Schwimmer JB, et al. Health-related quality of life in pediatric patients with irritable bowel syndrome: a comparative analysis. J Dev Behav Pediatr 2006; 27: 451-8.
5. Crowell MD, Harris L, Jones MP, Chang L,. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 2005; 7: 272-9.
6. Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
7. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T,. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G368-80.
8. Rhee SH, Im E, Riegler M, Kokkotou E, O'Brien M, Pothoulakis C,. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci U S A 2005; 102: 13610-5.
9. Rhee SH, Pothoulakis C, Mayer EA,. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-14.
10. Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-91.
11. Benninga MA, Voskuijl WP, Taminiau JA,. Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004; 39: 448-64.
12. Eddins C, Gray M,. Do probiotic or synbiotic preparations alleviate symptoms associated with constipation or irritable bowel syndrome? J Wound Ostomy Continence Nurs 2007; 34: 615-24.
13. Bausserman M, Michail S,. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005; 147: 197-201.
14. Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, et al. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 2010; 126: e1445-52.
15. Tabbers MM, Chmielewska A, Roseboom MG, Crastes N, Perrin C, Reitsma JB, et al. Fermented milk containing Bifidobacterium lactis DN-173 010 in childhood constipation: a randomized, double-blind, controlled trial. Pediatrics 2011; 127: e1392-9.
16. Banaszkiewicz A, Szajewska H,. Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. J Pediatr 2005; 146: 364-9.
17. Gill HS, Guarner F,. Probiotics and human health: a clinical perspective. Postgrad Med J 2004; 80: 516-26.
18. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45 (Suppl): S168-71.
19. Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, et al. Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health 2010; PMID 20626584. [Epub ahead of print].
20. Guerra PV, Lima LN, Souza TC, Mazochi V, Penna FJ, Silva AM, et al. Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial. World J Gastroenterol 2011; 17: 3916-21.
21. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
22. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
24. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC,. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 2007; 49: 485-90.
25. Guandalini S, Magazzu G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr 2010; 51: 24-30.
26. Gawronska A, Dziechciarz P, Horvath A, Szajewska H,. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007; 25: 177-84.
27. Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-32.
28. Ringel Y, Ringel-Kulka T,. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome. J Clin Gastroenterol 2011; 45 (Suppl): S145-8.
29. Balakrishnan M, Floch MH,. Prebiotics, probiotics and digestive health. Curr Opin Clin Nutr Metab Care 2012; 15: 580-5.
30. Horvath A, Dziechciarz P, Szajewska H,. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 2011; 33: 1302-10.
31. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil 2005; 17: 687-96
32. Niv E, Naftali T, Hallak R, Vaisman N,. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome-a double blind, placebo-controlled, randomized study. Clin Nutr 2005; 24: 925-31.
33. Agrawal A, Houghton LA, Morris J, Reilly B, Guyonnet D, Goupil Feuillerat N, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2009; 29: 104-14
34. Yang YX, He M, Hu G, Wei J, Pages P, Yang XH, et al. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 2008; 14: 6237-43.
35. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26: 475-86.
36. Solzi G, Di Lorenzo C,. Are constipated children different from constipated adults? Dig Dis 1999; 17: 308-15.